Andrew Shilling

Andrew Shilling, PhD, is a Global Product Portfolio Manager for Clinical and Commercial Supply, leveraging over 10 years of experience in scientific and operational roles within the pharmaceutical industry. Previously, they served as a Senior Quality Control Analyst and led the Analytical Method Development and Validations team at Croda, where they developed various testing methods for GMP products. Andrew's academic background includes a PhD in Chemistry and a BS in Biology from the University of South Florida, along with a current pursuit of an Executive MBA at the University of North Alabama. Known for critical thinking and clear communication, they excel at driving cross-functional initiatives and navigating complex regulatory environments.